Local News: Big Bend, CA 

 | 

Sign Up

 | 

Sign In

Advertisment

Nexium, Esomeprazole

Nexium, Esomeprazole Wire

Comprehensive News Feed for Nexium, Esomeprazole (generic).

Results 1 - 20 of 48 in Nexium, Esomeprazole (generic)

  1. FDA Advises Against Use of Clopidogrel With Omeprazole, Other Drugs

    Tuesday Nov 24 | American Academy of Family Physicians

    The FDA has issued a public health advisory warning consumers to avoid using the stomach acid reducer omeprazole, which is marketed in prescription and OTC formulations as Prilosec, with the anticlotting drug clopidogrel, which is marketed as Plavix.

    Comment?

    Related Topix: Medicine, Plavix, Clopidogrel (generic), Medication, Prilosec, Omeprazole (generic), Cimetidine (generic), Tagamet

  2. FDA: Avoid using Plavix with PrilosecRead the original story

    Thursday Nov 19 | ABC15.com

    According to the Food and Drug Administration, patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC with the anti-clotting drug Plavix.

    Comment?

    Related Topix: Prilosec, Omeprazole (generic), Medicine, Food and Drug Administration, Stroke, Health

  3. Effects of esomeprazole treatment for gastroesophageal reflux disease ...Read the original story

    Wednesday Nov 18 | BMC Gastroenterology

    Although gastroesophageal reflux disease is common in adolescents, the burden of GERD on health-related quality of life in adolescents has not been previously evaluated.

    Comment?

    Related Topix: Gastroesophageal Reflux Disease, Medicine, Health, Medication

  4. FDA reports significant drug interaction between PrilosecRead the original story w/Photo

    Sunday Nov 15 | Examiner.com

    The FDA has released information from studies showing an important drug interaction between proton pump inhibitors like omeprazole and clopidogrel .

    Comment?

    Related Topix: Prilosec, Omeprazole (generic), Medicine, Plavix, Clopidogrel (generic), Heartburn, Health

  5. Heartburn Drugs Reduce Plavix Effectiveness: FDARead the original story

    Tuesday Nov 17 | RedOrbit

    The popular heartburn drugs Prilosec and Nexium can reduce by nearly half the blood thinning effect of the drug Plavix, said officials with the U.S. Food and Drug Administration on Tuesday.

    Comment?

    Related Topix: Medicine, Plavix, Clopidogrel (generic), Medication, Food and Drug Administration, Prilosec, Omeprazole (generic)

  6. Omeprazole Decreases Effectiveness of Clopidogrel, FDA Says

    Tuesday Nov 17 | ASHP

    Patients who are taking clopidogrel should avoid the concomitant use of omeprazole, a proton-pump inhibitor , because the latter drug diminishes the antiplatelet effects of clopidogrel, FDA announced today.

    Comment?

    Related Topix: Medicine, Plavix, Clopidogrel (generic)

  7. AstraZeneca sues Lupin for infringing on drug patent

    Tuesday Nov 10 | Express India

    The drug is indicated in case of gastroesophageal reflux disease. The innovator has objected to all the five filings that Lupin has made in its Abbreviated New Drug Application to the US Food and Drug Administration to market the generic version of Nexium with strength 20 and 40 mg.

    Comment?

    Related Topix: Biotech, Medicine, AstraZeneca Group, Healthcare Industry, World News, India, New Delhi, India, Haryana, India, Medication, Gastroesophageal Reflux Disease, Health, Food and Drug Administration

  8. Schwarz Pharma, 126550Read the original story

    Friday Nov 6 | The Tribune

    The Ports of Indiana, Grantee of Foreign-Trade Zone No. 170, has applied to the Foreign-Trade Zones Board requesting special-purpose foreign-trade subzone status on behalf of Schwarz Pharma Manufacturing Limited.

    Comment?

    Related Topix: Seymour, IN, Univasc, Moexipril (generic), Medicine, Medication

  9. GERD Drugs May Cause Unexpected Side EffectsRead the original story

    Nov 1, 2009 | EMaxHealth

    People who are taking drugs called proton pump inhibitors to treat GERD and laryngopharyngeal reflux should be aware of possible unexpected side effects and complications, according to a new report published in Otolaryngologya 'Head and Neck Surgery .

    Comment?

    Related Topix: Medicine, Gerd, Health, Gastroesophageal Reflux

  10. Third-quarter fiscal 2009 results announced by POZENRead the original story

    Oct 28, 2009 | Medical News

    POZEN Inc. , today announced results for the third quarter ended September 30, 2009.

    Comment?

    Related Topix: Biotech, Medicine, Pozen, Healthcare Industry, AstraZeneca Group, Health

  11. POZEN Reports Third Quarter 2009 ResultsRead the original story

    Sep 30, 2009 | BusinessWire

    POZEN Inc. , today announced results for the third quarter ended September 30, 2009.

    Comment?

    Related Topix: Biotech, Medicine, Pozen, Healthcare Industry, Naproxen (generic), Aleve, Naprosyn, Medication, AstraZeneca Group, Imitrex, Sumatriptan (generic)

  12. Patients Taking Vimovo Showed a Decrease in Incidence of NSAID-Associated UlcersRead the original story

    Oct 23, 2009 | Drugs.com

    AstraZeneca and POZEN Inc. today announced pivotal data from two POZEN clinical trials that were presented at the American College of Rheumatology 2009 Annual Scientific Meeting in Philadelphia, PA.

    Comment?

    Related Topix: Biotech, AstraZeneca Group, Medicine, Pozen, Healthcare Industry, Naproxen (generic), Aleve, Naprosyn, Medication, Arthritis, Health, Osteoarthritis

  13. Patients Taking VIMOVO(TM) Showed A Decrease In Incidence Of NSAID-Associated UlcersRead the original story

    Oct 20, 2009 | Medical News Today

    Main Category: GastroIntestinal / Gastroenterology Also Included In: Arthritis / Rheumatology ; Conferences ; Clinical Trials / Drug Trials Article Date: 20 Oct 2009 - 1:00 PDT AstraZeneca and POZEN Inc.

    Comment?

    Related Topix: Medicine, Arthritis, Health, Biotech, Pozen, Healthcare Industry, AstraZeneca Group, Naproxen (generic), Aleve, Naprosyn, Medication, Osteoarthritis

  14. Missed Opportunities in the Trial on Proton-Pump Inhibitor Therapy in Bleeding Peptic UlcersRead the original story

    Oct 19, 2009 | Annals of Internal Medicine

    We thank all the correspondents for their considered comments. Ms. Yih and Dr. Tejani, Drs.

    Comment?

    Related Topix: Peptic Ulcer, Health, Food and Drug Administration

  15. AstraZeneca Submits Marketing Authorisation Application to European Union for VIMOVORead the original story

    Oct 16, 2009 | Pharmaceutical Processing

    AstraZeneca and POZEN Inc. today announced that they have submitted a Marketing Authorization Application in the European Union via the Decentralised Procedure for VIMOVOa tablets, a product under investigation for the treatment of the signs and symptoms of osteoarthritis , rheumatoid arthritis and ankylosing spondylitis in patients who are at risk ...

    Comment?

    Related Topix: Biotech, Medicine, Pozen, Healthcare Industry, AstraZeneca Group, Marketing, Naproxen (generic), Aleve, Naprosyn, Medication

  16. Medication Can Hasten Bone LossRead the original story

    Sep 2, 2009 | Seattle's WB

    Q: I take the acid blocker Nexium and expect that I will need to take it indefinitely.

    Comment?

    Related Topix: Medicine, Osteoporosis, Health

  17. Insights into the future of gastric acid suppressionRead the original story

    Sep 22, 2009 | Nature Publishing Group

    The development of effective acid-suppression therapy has revolutionized the treatment of acid-related diseases.

    Comment?

  18. Proton pump inhibitor dosing for the healing of erosive esophagitis

    Sep 6, 2009 | GastroHep.com News

    The latest issue of the Alimentary Pharmacology & Therapeutics compares standard- with double-dose proton pump inhibitors for the healing of severe erosive esophagitis.

    Comment?

    Related Topix: Medicine, AcipHex, Rabeprazole (generic)

  19. Pozen Announces FDA Acceptance of NDA For VimovoRead the original story

    Sep 1, 2009 | Drugs.com

    Aug 31, 2009 - POZEN Inc. today announced that the U.S. Food and Drug Administration has accepted the New Drug Application for Vimovo .

    Comment?

    Related Topix: Biotech, Medicine, Pozen, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Naproxen (generic), Aleve, Naprosyn, Medication, Health, Pain

  20. POZEN Announces FDA Acceptance Of NDA For VIMOVO™Read the original story

    Sep 2, 2009 | Medical News Today

    Main Category: Arthritis / Rheumatology Also Included In: Regulatory Affairs / Drug Approvals ; Bones / Orthopaedics Article Date: 02 Sep 2009 - 1:00 PDT POZEN Inc.

    Comment?

    Related Topix: Biotech, Medicine, Pozen, Healthcare Industry, Arthritis, Health, Food and Drug Administration, Naproxen (generic), Aleve, Naprosyn, Medication, Pain